Boston Scientific Corp (NYSE:BSX)
| 51.83 Delayed Data As of 4:00pm ET |  +0.33 / +0.64%Today’s Change | 34.98 Today|||52-Week Range 54.17 | +12.02% Year-to-Date |
| SECTOR Distribution Services | INDUSTRY Medical Distributors | MARKET CAP $73.4B |
Company Description
Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Urology and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979, and is headquartered in Marlborough, MA.
Contact Information
Boston Scientific Corp. 300 Boston Scientific Way Marlborough Massachusetts 01752-1234 |
Employees
Shareholders
| Mutual fund holders | 56.04% |
| Other institutional | 39.19% |
| Individual stakeholders | 1.42% |
Top Executives
| Michael F. Mahoney | Chairman, President & Chief Executive Officer |
| John Bradley Sorenson | Executive Vice President-Global Operations |
| Daniel J. Brennan | Chief Financial Officer & Executive Vice President |
| Jodi Eddy | Senior VP, Chief Information & Digital Officer |
| Ian T. Meredith | Global Chief Medical Officer & Executive VP |
